Journal List > J Korean Ophthalmol Soc > v.58(1) > 1010623

Kim and Kim: Characteristics in Patients with and without Previous Dacryocystitis and Satisfaction after Endonasal Dacryocystorhinostomy

Abstract

Purpose

To compare characteristics in patients with and without previous dacryocystitis and satisfaction after endoscopic dacryocystorhinostomy.

Methods

We retrospectively analyzed 156 eyes of 116 patients who underwent endoscopic dacryocystorhinostomy at our Hospital from May 2011 to December 2015. The patients were grouped into those with pre-operative dacryocystitis and those without dacryocystitis. Each patient group was characterized retrospectively, followed by a telephone survey regarding post-op-erative satisfaction.

Results

Fifty-eight patients (66 eyes) had dacryocystitis, whereas 58 patients (90 eyes) did not. Patients' mean age was 64.9 years old. The mean duration of symptoms in patients with and without dacryocystitis was 11 and 20 months, respectively, show-ing a statistically significant difference ( p < 0.05). The correlation between comorbidities and dacryocystitis was statistically insig-nificant ( p > 0.05). Post-operative satisfaction was higher in patients with dacryocystitis, showing a statistically significant differ-ence ( p < 0.05).

Conclusions

Patients with pre-operative dacryocystitis were characterized by a shorter duration of symptoms and higher post-operative satisfaction. This finding implies that post-operative satisfaction could be lower in patients without dacryocystitis, which should be noted.

References

1. Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 1961; 66:111–24.
2. Whittet HB, Shun-Shin GA, Awdry P. Functional endoscopic transnasal dacryocystorhinostomy. Eye (Lond). 1993; 7((Pt 4)):545–9.
crossref
3. Dolman PJ. Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy. Ophthalmology. 1961; 66:111–24.
crossref
4. Hii BW, McNab AA, Friebel JD. A comparison of external and en-donasal dacryocystorhinostomy in regard to patient satisfaction and cost. Orbit. 1961; 66:111–24.
crossref
5. Jutley G, Karim R, Joharatnam N, et al. Patient satisfaction follow-ing endoscopic endonasal dacryocystorhinostomy: a quality of life study. Eye (Lond). 1961; 66:111–24.
crossref
6. Ho A, Sachidananda R, Carrie S, Neoh C. Quality of life assess-ment after non-laser endonasal dacryocystorhinostomy. Clin Otolaryngol. 1961; 66:111–24.
crossref
7. Munk PL, Lin DT, Morris DC. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drain-age apparatus. Radiology. 1990; 177:687–90.
crossref
8. Wu W, Yan W, MacCallum JK, et al. Primary treatment of acute da-cryocystitis by endoscopic dacryocystorhinostomy with silicone intubation guided by a soft probe. Ophthalmology. 1961; 66:111–24.
crossref
9. Leong SC, Karkos PD, Burgess P, et al. A comparison of outcomes between nonlaser endoscopic endonasal and external dacryocysto-rhinostomy: single-center experience and a review of British trends. Am J Otolaryngol. 1961; 66:111–24.
crossref
10. Smirnov G, Tuomilehto H, Kokki H, et al. Symptom score ques-tionnaire for nasolacrimal duct obstruction in adults--a novel tool to assess the outcome after endoscopic dacryocystorhinostomy. Rhinology. 1961; 66:111–24.
crossref
11. Mannor GE, Millman AL. The prognostic value of preoperative da-cryocystography in endoscopic intranasal dacryocystorhinostomy. Am J Ophthalmol. 1961; 66:111–24.
crossref
12. Javate RM, Campomanes BS Jr, Co ND, et al. The endoscope and the radiofrequency unit in DCR surgery. Ophthal Plast Reconstr Surg. 1961; 66:111–24.
crossref
13. Rabina G, Golan S, Neudorfer M, Leibovitch I. External dacryocys-torhinostomy: characteristics and surgical outcomes in patients with and without previous dacryocystitis. J Ophthalmol 2013. 2013; 287524.
crossref
14. Kashkouli MB, Pakdel F, Hashemi M, et al. Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group. Orbit. 1961; 66:111–24.
crossref
15. McNab AA. Lacrimal canalicular obstruction associated with top-ical ocular medication. Aust N Z J Ophthalmol. 1961; 66:111–24.
crossref
16. Kashkouli MB, Rezaee R, Nilforoushan N, et al. Topical anti-glaucoma medications and lacrimal drainage system obstruction. Ophthal Plast Reconstr Surg. 1961; 66:111–24.
crossref
17. Mistry N, Rockley TJ, Reynolds T, Hopkins C. Development and validation of a symptom questionnaire for recording outcomes in adult lacrimal surgery. Rhinology. 1961; 66:111–24.
crossref
18. Sahlin S, Rose GE. Lacrimal drainage capacity and symptomatic improvement after dacryocystorhinostomy in adults presenting with patent lacrimal drainage systems. Orbit. 1961; 66:111–24.
crossref
19. Rose GE. The lacrimal paradox: toward a greater understanding of success in lacrimal surgery. Ophthal Plast Reconstr Surg. 2004; 20:262–5.
crossref

Table 1.
Demographics and characteristics of the patients
No past dacryocystitis Past dacryocystitis Total p-value
Sex (male:female) 22:36 20:38 42:74 0.080*
Age (years) 63.7 ± 2.7 66.1 ± 4.6 64.9 ± 3.6 0.101
Duration of epiphora (months) 20.3 ± 4.8 11.7 ± 4.8 16.0 ± 4.8 0.002

Values are presented as mean ± SD unless otherwise indicated.

* p-value by Pearson’s chi square test

p-value by independent t-test.

Table 2.
Comorbidities
No past dacryocystitis Past dacryocystitis Total p-value*
Hyperlipidemia 12 (20.6) 14 (24.1) 26 (22.4) 0.851
Diabetes mellitus type 2 4 (12.1) 8 (13.7) 12 (15.5) 0.594
Hypertension 24 (41.3) 28 (48.2) 52 (44.8) 2.427
Ischemic heart disease 8 (13.7) 4 (7.0) 12 (10.3) 0.214
Glaucoma 2 (3.4) 4 (6.8) 6 (5.1) 0.758

Values are presented as n (%) unless otherwise indicated.

* p-value by Pearson’s chi square test.

Table 3.
Comparison of response to the questions
No past dacryocystitis Past dacryocystitis p-value*
Score of satisfaction question 2.2 ± 0.6 2.6 ± 0.5 0.004
Score of symptom question 2.2 ± 0.7 2.5 ± 0.7 0.018

Values are presented as mean ± SD unless otherwise indicated.

* p-value by Mann-Whitney U-test.

TOOLS
Similar articles